Your browser doesn't support javascript.
loading
Targeting of colorectal cancer organoids with zoledronic acid conjugated to the anti-EGFR antibody cetuximab.
Benelli, Roberto; Costa, Delfina; Salvini, Laura; Tardito, Samuele; Tosetti, Francesca; Villa, Federico; Zocchi, Maria Raffaella; Poggi, Alessandro.
Afiliación
  • Benelli R; Molecular Oncology and Angiogenesis Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Costa D; Molecular Oncology and Angiogenesis Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Salvini L; Technologies Facilities, Fondazione Toscana Life Sciences, Siena, Italy.
  • Tardito S; Molecular Oncology and Angiogenesis Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Tosetti F; Molecular Oncology and Angiogenesis Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Villa F; Molecular Oncology and Angiogenesis Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Zocchi MR; Division of Immunology, Transplants and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Poggi A; Molecular Oncology and Angiogenesis Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy alessandro.poggi@hsanmartino.it.
J Immunother Cancer ; 10(12)2022 12.
Article en En | MEDLINE | ID: mdl-36543375

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Colorrectales / Inmunoconjugados Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Colorrectales / Inmunoconjugados Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Italia